Results 351 to 360 of about 19,469,886 (406)
Some of the next articles are maybe not open access.
Drug safety evaluation of defibrotide
Expert Opinion on Drug Safety, 2012Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), is a potentially life-threatening complication of chemotherapeutic conditioning used in preparation for hematopoietic stem-cell transplantation (SCT). Defibrotide (DF) has been shown in Phase II and III trials to improve complete response in patients with severe ...
Paul G, Richardson +13 more
openaire +2 more sources
Safety evaluation of hydrogenated oils
Food and Chemical Toxicology, 1990Processed foods have become an important part of the diet in industrialized countries. Advances in technology have brought about significant changes in the production methods in the food industry and have led to an improvement in texture, colour, shelflife and taste of conventional food products and to the development of novel foods.
P M, Verschuren, J L, Zevenbergen
openaire +2 more sources
Safety Evaluation of Biotechnology Products
Drug Safety, 1990Preclinical safety studies with biotechnology products are not only performed for regulatory purposes, but should first and foremost provide information about the potential toxic effects in patients. The initial toxicological experience, using standard testing procedures developed for drugs of small molecular weight, often gave disappointing results ...
openaire +2 more sources
Field evaluation of vaccine safety
Vaccine, 2004Surveillance of adverse events in the field represents an essential part of vaccination strategies. Safety studies conducted before vaccine licensure have often not enough power to detect rare or long-term adverse events. Furthermore, adverse events may be caused by incorrect procedures of storage or administration.
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
2010
To an even greater extent than is the case with pharmaceuticals, the regulatory nonclinical safety assessment requirement (called, for devices, biocompatability evaluation) has become globally harmonized. The primary guidance for the USA, EU, and Japan and associated countries have formally become the ISO 10993 standards, with each having reference ...
openaire +1 more source
To an even greater extent than is the case with pharmaceuticals, the regulatory nonclinical safety assessment requirement (called, for devices, biocompatability evaluation) has become globally harmonized. The primary guidance for the USA, EU, and Japan and associated countries have formally become the ISO 10993 standards, with each having reference ...
openaire +1 more source
An overview of real‐world data sources for oncology and considerations for research
Ca-A Cancer Journal for Clinicians, 2022Lynne Penberthy +2 more
exaly
SAFETY EVALUATION OF ETHAMBUTOL
Annals of the New York Academy of Sciences, 1966H F, Diermeier, J A, Kaiser, N, Yuda
openaire +2 more sources

